LIPOCINE INC. (LPCN) Return on equity 2016–2025
LIPOCINE INC. (LPCN) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-66.5%FY2025 · since FY2016: -72.9% → -66.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -66.5% | -66.5 pp |
| FY2024 | 0.0% | +80.3 pp |
| FY2023 | -80.3% | -50.1 pp |
| FY2022 | -30.2% | -28.8 pp |
| FY2021 | -1.4% | +135.3 pp |
| FY2020 | -136.7% | +70.2 pp |
| FY2019 | -206.9% | -83.3 pp |
| FY2018 | -123.6% | -13.0 pp |
| FY2017 | -110.6% | -37.6 pp |
| FY2016 | -72.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More LPCN financial trends
LPCN RevenueLPCN Net incomeLPCN Net marginLPCN Gross profitLPCN Gross marginLPCN Operating incomeLPCN Operating marginLPCN Operating cash flowLPCN Free cash flowLPCN Capital expendituresLPCN Stock buybacksLPCN Dividends paidLPCN Total assetsLPCN Total liabilitiesLPCN Shareholders’ equityLPCN overview →